Learn grant writing best practices from two experts who raised ~$4.7M in SBIR funds for their own medtech start up!
 

Write a Winning NIH SBIR/STTR Grant:

Master the Secrets to Securing Non-Dilutive Funding

 
Are you a medical device startup or small business looking for funding? The NIH SBIR/STTR program offers a game-changing opportunity—but competition is fierce. Even if you're new to SBIR grants or have faced rejection before, this webinar will provide insider strategies from successful recipients to dramatically improve your chances of securing funding.
Register Now
 

Write a Winning NIH SBIR/STTR Grant:

Master the Secrets to Securing Non-Dilutive Funding

 

Are you a medical device startup or small business looking for funding? The NIH SBIR/STTR program offers a game-changing opportunity—but competition is fierce. Even if you're new to SBIR grants or have faced rejection before, this webinar will provide insider strategies from successful recipients to dramatically improve your chances of securing funding.
Register Now


FREE LIVE WEBINAR 
MAY 5, 2025 
11:00 AM CST

Secure Non-Dilutive Funding   
with a Winning NIH SBIR/STTR Grant!  

 

Are you a small business or startup in the medical device industry looking for funding? NIH SBIR/STTR grants provide a non-dilutive way to support your innovation—but competition is fierce. Thousands of qualified applicants get denied every year. Do you know what it takes to win?  

Join us for this expert-led webinar where we’ll break down the 5 key NIH SBIR/STTR review categories and show you how to position your grant for success. Your hosts are previous winners of multiple SBIR grants.  They have written and received Phase I, Phase II and Phase IIB SBIR grants securing ~$4.7M for their own medical device startup, which they were able to leveage and bring to a commercial deal. They have also helped dozens of other clients raise millions in NIH SBIR/STTR funding!

This webinar will help you:  

✅ Understand the 5 critical NIH SBIR/STTR Review Categories and how to optimize your application:  

  • Investigators: Prove your team has the right expertise  
  • Environment: Demonstrate that you have the right resources and facilities  
  • Significance: Show how your innovation addresses a real problem  
  • Innovation: Make your proposal stand out from competitors  
  • Approach: Build a research and development plan that wins reviewers over  

✅ Develop a compelling commercialization plan that increases your funding potential  

✅ Avoid common mistakes that lead to rejection and learn how to strengthen weak spots in your application  

✅ Craft a regulatory strategy that aligns with funding and market success  

✅ Gain insider tips directly from two former SBIR/STTR recipients and reviewers to improve your grant’s competitiveness  

 

Register for the Webinar 
  

Get started today before this once in a lifetime opportunity expires.

By submitting your information, you consent to receive occasional emails from Ventura Solution and the presenting partner. You can unsubscribe at any time. For more details, please review our privacy policy here.

00

DAYS

00

HOURS

00

MINS

00

SECS


FREE LIVE WEBINAR 
APRIL 17, 2025 
11:00 AM CST

Secure Non-Dilutive Funding   
with a Winning NIH SBIR/STTR Grant!  

 

Are you a small business or startup in the medical device industry looking for funding? NIH SBIR/STTR grants provide a non-dilutive way to support your innovation—but competition is fierce. Thousands of qualified applicants get denied every year. Do you know what it takes to win?  
Join us for this expert-led webinar where we’ll break down the 5 key NIH SBIR/STTR review categories and show you how to position your grant for success. Your hosts are previous winners of multiple SBIR grants.  They have written and received Phase I, Phase II and Phase IIB SBIR grants securing ~$4.7M for their own medical device startup, which they were able to leveage and bring to a commercial deal. They have also helped dozens of other clients raise millions in NIH SBIR/STTR funding!

This webinar will help you:  
✅ Understand the 5 critical NIH SBIR/STTR Review Categories and how to optimize your application:  
  • Investigators: Prove your team has the right expertise  
  • Environment: Demonstrate that you have the right resources and facilities  
  • Significance: Show how your innovation addresses a real problem  
  • Innovation: Make your proposal stand out from competitors  
  • Approach: Build a research and development plan that wins reviewers over  
✅ Develop a compelling commercialization plan that increases your funding potential  
✅ Avoid common mistakes that lead to rejection and learn how to strengthen weak spots in your application  
✅ Craft a regulatory strategy that aligns with funding and market success  
✅ Gain insider tips directly from two former SBIR/STTR recipients and reviewers to improve your grant’s competitiveness  

 

Register for the Webinar 
  

Get started today before this once in a lifetime opportunity expires.

By submitting your information, you consent to receive occasional emails from Ventura Solution and the presenting partner. You can unsubscribe at any time. For more details, please review our privacy policy here.

00

DAYS

00

HOURS

00

MINS

00

SECS

Learn from the Experts Who Raised ~$4.7M in NIH SBIR Funding for Their Own Start Up, and Helped Others Raise Millions More!

Learn from the Experts Who Raised ~$4.7M in NIH SBIR Funding for Their Own Start Up, and Helped Others Raise Millions More!

Patrick Rousche

Director of Research and Development and non-dilutive Grant Funding

Dr. Rousche is the Director of Research and Development and non-dilutive Grant Funding at Ventura Solutions. He received a B.S in Bioengineering in from Syracuse University and a Ph.D. in Bioengineering in from the University of Utah. Since then, he served as a tenured and award-winning professor of bioengineering at the University of Illinois at Chicago and as the Chief Scientific Officer of Hemotek Medical Inc, amassing over 20 years of biomedical engineering research and development experience. He has published multiple scientific journal articles and served on numerous grant review panels, including those for medical device development. He has raised ~$4.7 million dollars in non-dilutive funding for his own medical device start-up and tens of millions for clients. Dr. Rousche is responsible for working with clients on non-dilutive grant funding, concept development, and exploratory testing. 

Chuck Ventura

Founder & Chief Executive Officer

Chuck Ventura is the Founder and Chief Executive Officer of Ventura Solutions. He is a seasoned medical device and combination products leader with expertise in commercialization, R&D, project management, quality, regulatory affairs, manufacturing, and entrepreneurship.

Chuck is also the co-founder and CEO of Hemotek Medical, where he led the company from a napkin sketch to a commercial deal, securing ~$4.7M in NIH SBIR funding along the way. At Hemotek, he heads regulatory and quality for new product development, ensuring market success.

Before launching Ventura Solutions, Chuck was the R&D Combination Product Systems Engineering Manager at Pfizer and held leadership roles at Hospira and Baxter Healthcare. He holds a B.S. in Biomedical Engineering with a minor in Electrical Engineering from the University of Illinois at Chicago and a Master’s in Mechanical and Aerospace Engineering from the Illinois Institute of Technology.

Chuck and Patrick aren’t just advisors, they’ve been in your shoes. They successfully raised $4.7 million for their own medical device startup and have helped other companies secure millions more in non-dilutive funding. 
 
Join our webinar to learn their proven strategies for winning NIH SBIR/STTR grants and unlocking the funding your innovation deserves.
Claim Your Free Spot Now!
Patrick Rousche

Director of Research and Development and non-dilutive Grant Funding

Dr. Rousche is the Director of Research and Development and non-dilutive Grant Funding at Ventura Solutions. He received a B.S in Bioengineering in from Syracuse University and a Ph.D. in Bioengineering in from the University of Utah. Since then, he served as a tenured and award-winning professor of bioengineering at the University of Illinois at Chicago and as the Chief Scientific Officer of Hemotek Medical Inc, amassing over 20 years of biomedical engineering research and development experience. He has published multiple scientific journal articles and served on numerous grant review panels, including those for medical device development. He has raised ~$4.7 million dollars in non-dilutive funding for his own medical device start-up and tens of millions for clients. Dr. Rousche is responsible for working with clients on non-dilutive grant funding, concept development, and exploratory testing. 

Chuck Ventura

Chief Executive Officer

Chuck Ventura is the founder and Chief Executive Officer of Ventura Solutions. He is a seasoned medical device and combination products leader with successful experience in commercialization, R&D, project management, quality, regulatory, manufacturing, and entrepreneurship. Chuck is also the co-founder and CEO of Hemotek Medical, where he is responsible for the strategic vision as well as business operations. At Hemotek, Chuck also serves as the head of regulatory and quality for all new product development, where he and his team have taken Hemotek’s core product from a product napkin sketch to a commercial deal with ~$4.7M in NIH SBIR funding. Prior to founding Ventura Solutions, Chuck was the R&D Combination Product Systems Engineering Manager at Pfizer. He also has experience with many other medical device companies, such as Hospira and Baxter Healthcare. Chuck received his bachelor’s degree in Biomedical Engineering with a minor in Electrical Engineering from the University of Illinois at Chicago. After receiving his bachelor’s degree, Chuck then went on to earn his master’s degree in Mechanical and Aerospace Engineering from the Illinois Institute of Technology. Outside of work, Chuck enjoys spending time with his family and friends, playing music, and giving back to the community.

Chuck and Patrick aren’t just advisors, they’ve been in your shoes. They successfully raised $4.7 million for their own medical device startup and have helped other companies secure millions more in non-dilutive funding. 
 
Join our webinar to learn their proven strategies for winning NIH SBIR/STTR grants and unlocking the funding your innovation deserves.
Claim Your Free Spot Now!